/ TMO


Thermo Fisher (TMO) Delivers Q3 Beat, Highlights Positive 2025 Outlook
/ Earnings

Thermo Fisher (TMO) Delivers Q3 Beat, Highlights Positive 2025 Outlook

Thermo Fisher Scientific reported 5% revenue growth in Q3 2025 with adjusted EPS of $5.79, beating expectations and reinforcing its positive long-term outlook.

October 22, 2025
Thermo Fisher Scientific’s Reports Strong Q2 2025 Results

Thermo Fisher Scientific’s Reports Strong Q2 2025 Results

Thermo Fisher Scientific's second quarter of 2025 demonstrated a 3% revenue increase to $10.85 billion, slightly surpassing expectations.

July 23, 2025
Thermo Fisher Scientific Inc. (TMO) Beats EPS Expectations in Q3, Slight Miss on Revenue

Thermo Fisher Scientific Inc. (TMO) Beats EPS Expectations in Q3, Slight Miss on Revenue

Thermo Fisher Scientific Inc. (NYSE: TMO) reported a revenue of $10.60 billion in the third quarter of 2024.

October 23, 2024
Thermo Fisher Scientific Inc. (NYSE: TMO) Achieves 15% Growth in Q2 Diluted EPS

Thermo Fisher Scientific Inc. (NYSE: TMO) Achieves 15% Growth in Q2 Diluted EPS

Thermo Fisher Scientific reported $10.54 billion in revenue for Q2 2024.

July 24, 2024
Thermo Fisher Scientific (TMO) Reports Q1 Beat with $5.11 EPS and $10.34 B in Revenue

Thermo Fisher Scientific (TMO) Reports Q1 Beat with $5.11 EPS and $10.34 B in Revenue

Thermo Fisher Scientific Inc. has showcased its financial strength in the first quarter of 2024, with a slight revenue decline but commendable growth in GAAP diluted earnings per share.

April 24, 2024

More from The Tokenist / TMO

Get Trade Ideas and Market Insights Delivered to You Premarket - Every Day

X